Published September 2021
| Version v1
Journal article
Stereotactic radiosurgery for brain metastases from small cell lung cancer without prior whole-brain radiotherapy: A meta-analysis
- 1. Ribeirão Preto Medical School, Department of Medical Imagings, Hematology and Oncology of University of São Paulo (FMRP-USP) (Brazil)
- 2. Radiation Oncology Department - Americas Centro de Oncologia Integrado, Rio de Janeiro (Brazil)
- 3. Sunnybrook Health Sciences Centre, Toronto (Canada)
- 4. Department of Oncology - Division of Radiation Oncology, Kingston General Hospital, Queen's University, Kingston (Canada)
Description
Highlights: • Stereotactic radiosurgery (SRS) as an upfront treatment for small cell lung cancer (SCLC) is controversial. • The meta-analysis showed a favorable outcome for local control and overall survival in high selected patients with SRS. • The salvage treatment of distant brain failures resulted in a reduced risk of neurological death. • These findings support the design of future randomized clinical trials. Assess upfront Stereotactic radiosurgery (SRS) effectiveness for small cell lung cancer (SCLC) brain metastases (BM). Where possible, a comparison with whole-brain radiotherapy (WBRT) was performed.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.radonc.2021.06.026Additional details
Identifiers
- DOI
- 10.1016/j.radonc.2021.06.026;
- PII
- S0167814021066093;
Publishing Information
- Journal Title
- Radiotherapy and Oncology
- Journal Volume
- 162
- Journal Page Range
- p. 45-51
- ISSN
- 0167-8140
- CODEN
- RAONDT
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 54014099
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BRAIN; CLINICAL TRIALS; DEATH; FAILURES; LUNGS; METASTASES; NEOPLASMS; PATIENTS; RADIOTHERAPY; SURGERY
- Descriptors DEC
- BODY; CENTRAL NERVOUS SYSTEM; DISEASES; MEDICINE; NERVOUS SYSTEM; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RESPIRATORY SYSTEM; TESTING; THERAPY
Optional Information
- Copyright
- Copyright (c) 2021 Elsevier B.V. All rights reserved.